A Post-Market Clinical Follow-up Study in Patients Treated With Vascular Grafts

Inclusion Criteria: * Patient ≥ 18 years at time of written informed consent * Patient was selected for treatment with a commercially available Vascular Graft of JOTEC * Patient satisfies at least one of the following categories: * Acute (14 days) / subacute (15 - 90 days) dissection with double lumina in the aorta or peripheral artery / arteries (lower limb) * Chronic (\>90 days) dissection with double lumina in the aorta or peripheral artery / arteries (lower limb) * Aneurysm in the aorta or peripheral artery / arteries (lower limb) * IMH in the aorta or peripheral artery / arteries (lower limb) * PAU in the aorta or peripheral artery / arteries (lower limb) * Contained rupture in the aorta or peripheral artery / arteries (lower limb) * Stenosis in the aorta or peripheral artery / arteries (lower limb) * Debranching of head vessels * AV shunt * Patient is willing and able to comply with all clinical study procedures and study visits. * Patient has given written informed consent to participate in the study. Exclusion Criteria: * Patient has any other medical, social, or psychological problem that in the opinion of the investigator preclude them from receiving this treatment, procedures, and evaluations pre- and post-procedure. * Patient is scheduled for reconstruction of the tibial artery